PF
BSX icon

Phoenix Financial’s Boston Scientific BSX Stock Holding History

Phoenix Financial’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$941 Buy
+15,000
New +$1.2M ﹤0.01% 486
2024
Q1 		– Sell
-12,800
Closed -$740 – 434
2023
Q4 		$740 Buy
+12,800
New +$683K ﹤0.01% 343

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Phoenix Financial's BSX Position: Q1 2026 in Review

Phoenix Financial increased its Boston Scientific (BSX) stake by 2,286% in Q1 2026, buying an estimated $119M and bringing the position to 1,550,372 shares worth $97.3M. The position accounts for 0.92% of the portfolio, ranked #29.

Phoenix Financial first reported a position in BSX in Q3 2020 and has held it in 23 quarters since. 1,672 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Phoenix Financial held 1,550,372 shares of Boston Scientific worth $97.3M as of Q1 2026.
  • Phoenix Financial bought 1,485,404 Boston Scientific shares in Q1 2026, an estimated $119M.
  • Boston Scientific made up 0.92% of Phoenix Financial's portfolio in Q1 2026, its #29 holding.
  • Phoenix Financial first reported a position in Boston Scientific in Q3 2020 and has held it in 23 quarters since.
  • 1,672 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Phoenix Financial's 13F filing for Q1 2026, filed 11 May 2026.